Scandinavian Tobacco Group (STG) Q2 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2026 earnings summary
27 Aug, 2026Executive summary
Focus2030 strategy execution is progressing, prioritizing stabilization of machine-rolled cigars and smoking tobacco, growth in handmade cigars, and expansion in nicotine pouches.
Net sales stabilized at DKK 4.2 billion for H1 2026, with a 3% negative currency impact and organic net sales nearly flat.
Handmade cigars delivered 6% organic net sales growth, while machine-rolled cigars & smoking tobacco declined 4%.
Divestment of BREAK and Moro brands to Japan Tobacco for DKK 1.3 billion (EUR 176 million), with post-tax proceeds of DKK 1.0 billion, will enhance strategic and financial flexibility.
The group remains on track to meet full-year 2026 expectations.
Financial highlights
H1 2026 net sales: DKK 4,193 million, down 3% year-over-year, mainly due to negative currency effects; Q2 2026: DKK 2,334 million, down 1%.
EBITDA before special items: DKK 835 million (H1), up 2%; margin at 19.9% (H1 2025: 18.8%).
EBIT margin before special items: 13.8% (H1), up from 13.7% in H1 2025; increased trademark amortization impacted EBIT by DKK 38 million.
Free cash flow before acquisitions: DKK 422 million (H1), up nearly DKK 150 million year-over-year.
Leverage ratio at 3.0x, expected to fall below 2.5x after divestment completion.
Outlook and guidance
2026 group net sales growth at constant currencies expected between -2% and +2%.
EBIT margin before special items forecasted at 13%-14.5%, down from 14.9% in 2025.
Free cash flow before acquisitions expected at DKK 950 million–1.2 billion; adjusted EPS DKK 9–11.
Leverage ratio targeted to move toward 2.5x by year-end, assuming divestment closes.
Guidance excludes effects from BREAK and Moro divestment.
Latest events from Scandinavian Tobacco Group
- 2025 saw lower earnings and a new strategy focused on cigars, nicotine pouches, and sustainability.STG
AGM 2026 presentation - Stable margins and cash flow amid 6% sales decline; handmade cigars up 8% organically.STG
Q1 2026 - 2025 results declined, but Focus2030 and strong cash flow support a stable 2026 outlook.STG
Q4 2025 - Focus2030 targets growth in cigars and nicotine pouches, efficiency, and flexible shareholder returns.STG
CMD 2025 - Q3 net sales up 7.1% on Mac Baren deal; EBITDA margin and organic growth declined.STG
Q3 2024 - Q2 2024 saw 6.3% sales growth, margin gains, and a strategic acquisition for future expansion.STG
Q2 2024 - Record net sales and higher dividend proposed, with all board proposals approved.STG
AGM 2025 - Organic sales fell 8.8% in Q1 2025, prompting lower guidance amid US and FX headwinds.STG
Q1 2025 - Net sales up 5.4% to DKK 9.2bn, but profit down 20.5% amid margin pressure and investments.STG
Q4 2024